Clinical Trial

Cannabis, Neuroinflammation, and Suicidal Ideation: A Supplemental Brain Imaging Study

Study acronym: CNS
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This study will be the first to use brain imaging to explore how cannabis affects the brain and inflammation in U.S. military veterans with PTSD. It builds on an ongoing study testing different combinations of THC and CBD in 200 veterans. In this project, up to 100 veterans will complete brain scans before and after 12 weeks of cannabis administration to see how the brain changes over time. The scans will measure a marker sensitive to neuroinflammatory state, brain communication, and activity during thinking and emotion tasks. By linking these brain changes to improvements in PTSD symptoms, suicidal thoughts, and quality of life, this study may help identify which veterans benefit most from cannabis-based treatments and support more personalized care for PTSD.
Trial Details
NCT Number NCT07222306
Lead Sponsor Wayne State University
Collaborators: Barbara Ann Karmanos Cancer Institute
Conditions PTSD, Suicidal Thoughts and Behaviors, PTSD Symptoms, Depressive Symptoms
Enrollment 100 participants
Start Date 2026-01-01
Primary Completion 2030-08-31 (estimated)
Study Completion 2030-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-06